Eli Lilly and Company (NYSE:LLY) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 6:45 PM ET Company Participants Anat Ashkenazi - Chief Financial Officer Daniel Skovronsky - Chief Scientific and Medical Officer Conference Call Participants Christopher Schott - J.P. Morgan Christopher Schott Good afternoon, everybody. I'm Chris Schott at J.P. Morgan, and it's my pleasure to be hosting this fireside chat with Eli Lilly. Lilly has obviously had a tremendous few years here and very much looking f ...

Eli Lilly and Company (NYSE:LLY) 5th Annual Evercore ISI HealthCONx Conference 2022 Conference Call November 30, 2022 12:10 PM ET Company Participants Jacob Van Naarden - Executive Vice President and Chief Executive Officer, Loxo@Lilly David Hyman - Chief Medical Officer, Loxo@Lilly Joe Fletcher - SVP, IR Conference Call Participants Umer Raffat - Evercore ISI Umer Raffat Excellent. Thank you, guys for joining us. It's a pleasure to have Eli Lilly management join us. There's a lot to talk about, but before ...

Eli Lilly and Co (NYSE:LLY) Q3 2022 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat Ashkenazi - SVP & CFO Daniel Skovronsky - Chief Scientific and Medical Officer Anne White - SVP & President, Lilly Neuroscience Ilya Yuffa - SVP & President, Lilly International Lilly Research Labs Jake Van Naarden - SVP, CEO, Loxo Oncology & President, Lilly Oncology Michael Mason - SVP & President, Lilly Diabetes Conference Call P ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 COMMISSION FILE NUMBER 001-6351 ELI LILLY AND COMPANY (Exact name of Registrant as specified in its charter) Indiana 35-0470950 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Lilly Corporate Center, Indianapolis, Indiana 46285 (Address and ...

Eli Lilly and Company (NYSE:LLY) Morgan Stanley 20th Annual Global Healthcare Conference September 13, 2022 11:10 AM ET Company Participants Anat Ashkenazi - Senior Vice President and Chief Financial Officer Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Great. Well, thanks, everybody, for joining us. I'm Terence Flynn, the U.S. Pharma analyst here at Morgan Stanley. We're very pleased to be hosting Eli Lilly today. Joining us from the company is Anat Ashkenazi, who is the company ...

Call Start: 15:30 January 1, 0000 4:14 PM ET Eli Lilly and Company (NYSE:LLY) Citigroup 17th Annual BioPharma Conference Call September 7, 2022 15:30 ET Company Participants Dan Skovronsky - Chief Scientific Officer, Chief Medical Officer & President of R&D Conference Call Participants Andrew Baum - Citigroup Andrew Baum So, good afternoon. Welcome back. Delighted to introduce our session. We have from Lilly, Dan Skovronsky, the CSO, CMO and President of Lilly R&D. Did I get that right? Dan Skovronsky Yes, ...

Eli Lilly and Company (NYSE:LLY) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Company Participants Kevin Hern - Vice President of Investor Relations Dave Ricks - Chair & Chief Executive Officer Anat Ashkenazi - Chief Financial Officer Dan Skovronsky - Chief Scientific Officer & Chief Medical Officer Mike Mason - President of Lilly Diabetes Ilya Yuffa - President of Lilly International Jake Van Naarden - Chief Executive Officer, Loxo Oncology, Lilly & President, Lilly Oncology Conference Call P ...